Kay M. Ristow

4.6k citations
76 papers · 2.9k indexed · h-index 31
Topics
Lymphoma Diagnosis and Treatment (72 papers)Viral-associated cancers and disorders (33 papers)Chronic Lymphocytic Leukemia Research (11 papers)

In The Last Decade

Kay M. Ristow

73 papers receiving 2.8k citations

Peers

Kay M. Ristow
Comparison fields: 5 of 80
  • Pathology and Forensic Medicine 1.8k
  • Oncology 1.7k
  • Immunology 616
  • Genetics 487
  • Neurology 417
Replace R. Gregory Bociek with:
R. Gregory Bociek United States
Emilio Iannitto Italy
Luís Colomo Spain
Luigi Rigacci Italy
Jooryung Huh South Korea
Karamjit Gill Canada
Ilske Oschlies Germany
Onsi W. Kamel United States
Jehan Dupuis France
Catherine Sebban France
Kay M. Ristow relative to R. Gregory Bociek United States R. Gregory Bociek's profile →
Citations per field
00.5×1.5×
R. Gregory Bociek · 1×
Citations per year

Countries citing papers authored by Kay M. Ristow

Since Specialization
Citations

This map shows the geographic impact of Kay M. Ristow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay M. Ristow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay M. Ristow more than expected).

Fields of papers citing papers by Kay M. Ristow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay M. Ristow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay M. Ristow. The network helps show where Kay M. Ristow may publish in the future.

Co-authorship network of co-authors of Kay M. Ristow

This figure shows the co-authorship network connecting the top 25 collaborators of Kay M. Ristow. A scholar is included among the top collaborators of Kay M. Ristow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay M. Ristow. Kay M. Ristow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 1
3 55
4 40
5 19
6 43
7 16
8 100
9 42
10 161
11 76
12 152
13 45
14 44
15 46
16 90
17 114
18 37
19 70
20 83

About Kay M. Ristow

Kay M. Ristow is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 76 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (72 papers), Viral-associated cancers and disorders (33 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.8k citations), Oncology (1.7k citations) and Genetics (487 citations). Kay M. Ristow has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Thomas M. Habermann, Stephen M. Ansell, Thomas E. Witzig, David J. Inwards, Joseph P. Colgan, Luis F. Porrata, Ivana N. Micallef, Patrick B. Johnston, Svetomir N. Markovic and William R. Macon. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026